These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16697868)

  • 1. Triclosan loaded ureteral stents decrease proteus mirabilis 296 infection in a rabbit urinary tract infection model.
    Cadieux PA; Chew BH; Knudsen BE; Dejong K; Rowe E; Reid G; Denstedt JD
    J Urol; 2006 Jun; 175(6):2331-5. PubMed ID: 16697868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of triclosan eluting stents effectively reduces ureteral stent symptoms: a prospective randomized trial.
    Mendez-Probst CE; Goneau LW; MacDonald KW; Nott L; Seney S; Elwood CN; Lange D; Chew BH; Denstedt JD; Cadieux PA
    BJU Int; 2012 Sep; 110(5):749-54. PubMed ID: 22313688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of triclosan-eluting ureteral stents against common bacterial uropathogens.
    Chew BH; Cadieux PA; Reid G; Denstedt JD
    J Endourol; 2006 Nov; 20(11):949-58. PubMed ID: 17144870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of triclosan-eluting ureteral stents in patients with long-term stents.
    Cadieux PA; Chew BH; Nott L; Seney S; Elwood CN; Wignall GR; Goneau LW; Denstedt JD
    J Endourol; 2009 Jul; 23(7):1187-94. PubMed ID: 19538062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swarming of Proteus mirabilis over ureteral stents: a comparative assessment.
    Watterson JD; Cadieux PA; Stickler D; Reid G; Denstedt JD
    J Endourol; 2003 Sep; 17(7):523-7. PubMed ID: 14565887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of triclosan on the development of bacterial biofilms by urinary tract pathogens on urinary catheters.
    Jones GL; Muller CT; O'Reilly M; Stickler DJ
    J Antimicrob Chemother; 2006 Feb; 57(2):266-72. PubMed ID: 16339844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An improved model of a catheterised human bladder for screening bactericidal agents].
    Schulz A; Vestweber AM; Leis W; Stark D; Dressler D
    Aktuelle Urol; 2008 Jan; 39(1):53-7. PubMed ID: 18228188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high throughput, minimally invasive, ultrasound guided model for the study of catheter associated urinary tract infections and device encrustation in mice.
    Janssen C; Lo J; Jäger W; Moskalev I; Law A; Chew BH; Lange D
    J Urol; 2014 Dec; 192(6):1856-63. PubMed ID: 24866596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel rabbit model for the evaluation of biomaterial associated urinary tract infection.
    Fung LC; Mittelman MW; Thorner PS; Khoury AE
    Can J Urol; 2003 Oct; 10(5):2007-12. PubMed ID: 14633329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A strategy for the control of catheter blockage by crystalline Proteus mirabilis biofilm using the antibacterial agent triclosan.
    Jones GL; Russell AD; Caliskan Z; Stickler DJ
    Eur Urol; 2005 Nov; 48(5):838-45. PubMed ID: 16126323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive and therapeutic administration of an indigenous Lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model.
    Fraga M; Scavone P; Zunino P
    Antonie Van Leeuwenhoek; 2005 Jul; 88(1):25-34. PubMed ID: 15928974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Susceptibility of Proteus mirabilis to triclosan.
    Stickler DJ; Jones GL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):991-4. PubMed ID: 18180352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technology insight: Novel ureteral stent materials and designs.
    Chew BH; Denstedt JD
    Nat Clin Pract Urol; 2004 Nov; 1(1):44-8. PubMed ID: 16474466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity Study of triclosan-loaded WBPU on Proteus mirabilis in vitro.
    Tian Y; Jian Z; Wang J; He W; Liu Q; Wang K; Li H; Tan H
    Int Urol Nephrol; 2017 Apr; 49(4):563-571. PubMed ID: 28150092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diamond-like carbon coatings on ureteral stents--a new strategy for decreasing the formation of crystalline bacterial biofilms?
    Laube N; Kleinen L; Bradenahl J; Meissner A
    J Urol; 2007 May; 177(5):1923-7. PubMed ID: 17437849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in ureteral stent design, materials and coatings.
    Chew BH; Duvdevani M; Denstedt JD
    Expert Rev Med Devices; 2006 May; 3(3):395-403. PubMed ID: 16681460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Native flagellin does not protect mice against an experimental Proteus mirabilis ascending urinary tract infection and neutralizes the protective effect of MrpA fimbrial protein.
    Scavone P; Umpiérrez A; Rial A; Chabalgoity JA; Zunino P
    Antonie Van Leeuwenhoek; 2014 Jun; 105(6):1139-48. PubMed ID: 24771125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro multicompartmental bladder model for assessing blockage of urinary catheters: effect of hydrogel coating on dynamics of Proteus mirabilis growth.
    Kazmierska KA; Thompson R; Morris N; Long A; Ciach T
    Urology; 2010 Aug; 76(2):515.e15-20. PubMed ID: 20696356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 'buoy' stent: evaluation of a prototype indwelling ureteric stent in a porcine model.
    Krebs A; Deane LA; Borin JF; Edwards RA; Sala LG; Khan F; Abdelshehid C; McDougall EM; Clayman RV
    BJU Int; 2009 Jul; 104(1):88-92. PubMed ID: 19154469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a silicone urinary catheter impregnated with chlorhexidine and triclosan against colonization with Proteus mirabilis and other uropathogens.
    Gaonkar TA; Caraos L; Modak S
    Infect Control Hosp Epidemiol; 2007 May; 28(5):596-8. PubMed ID: 17464922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.